2019
DOI: 10.1016/j.nlm.2019.02.002
|View full text |Cite
|
Sign up to set email alerts
|

After-effects of repetitive anodal transcranial direct current stimulation on learning and memory in a rat model of Alzheimer’s disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
21
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 20 publications
(24 citation statements)
references
References 37 publications
3
21
0
Order By: Relevance
“…Therefore, the level of GFAP expression in the AD group was significantly higher than that in the CTL group (Figures 5C, 7B). In the ADT group treated with AtDCS, GFAP expression levels were decreased, and Aβ 42 was surrounded by activated astrocytes (Figure 7C), which is consistent with previous studies (Itagaki et al, 1989;Yu et al, 2015;Zhu et al, 2017;Yang et al, 2019). However, AtDCS increases glial activation in the early stages and decreases with time (Rueger et al, 2012;Pikhovych et al, 2016).…”
Section: Discussionsupporting
confidence: 91%
See 3 more Smart Citations
“…Therefore, the level of GFAP expression in the AD group was significantly higher than that in the CTL group (Figures 5C, 7B). In the ADT group treated with AtDCS, GFAP expression levels were decreased, and Aβ 42 was surrounded by activated astrocytes (Figure 7C), which is consistent with previous studies (Itagaki et al, 1989;Yu et al, 2015;Zhu et al, 2017;Yang et al, 2019). However, AtDCS increases glial activation in the early stages and decreases with time (Rueger et al, 2012;Pikhovych et al, 2016).…”
Section: Discussionsupporting
confidence: 91%
“…Compared with the CTL group, the AD group and the ADT group had different expression levels of GFAP, indicating that the AD group and the ADT mice had different degrees of inflammatory abnormalities, consistent with our previous studies (Yu et al, 2015;Yang et al, 2019). Neuroinflammation is an early pathological manifestation in the AD brain and is a basic protective immune response in the central nervous system (Eikelenboom et al, 2010).…”
Section: Discussionsupporting
confidence: 88%
See 2 more Smart Citations
“…tDCS of the DLPFC and temporal regions has also shown to improve neurocognitive function in AD patients (213). In rat models of AD, tDCS has shown to increase hippocampal acetylcholine, choline acetyltransferase and glial fibrillary acidic protein expression (218,219).…”
Section: Noninvasive Neuromodulationmentioning
confidence: 99%